Dark Forest Capital Management’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$316K Sell
17,710
-25,370
-59% -$454K 0.02% 727
2026
Q1
$770K Sell
43,080
-35,083
-45% -$767K 0.07% 444
2025
Q4
$2.11M Buy
78,163
+46,506
+147% +$1.31M 0.1% 369
2025
Q3
$958K Buy
+31,657
New +$1.01M 0.04% 756

Other funds holding CAI

Dark Forest Capital Management's CAI Position: Q2 2026 in Review

Dark Forest Capital Management reduced its Caris Life Sciences (CAI) stake by 59% in Q2 2026, selling an estimated $454K and leaving 17,710 shares worth $316K. The position accounts for 0.02% of the portfolio, ranked #727.

Dark Forest Capital Management first reported a position in CAI in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.11M in Q4 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Dark Forest Capital Management held 17,710 shares of Caris Life Sciences worth $316K as of Q2 2026.
  • Dark Forest Capital Management sold 25,370 Caris Life Sciences shares in Q2 2026, an estimated $454K.
  • Caris Life Sciences made up 0.02% of Dark Forest Capital Management's portfolio in Q2 2026, its #727 holding.
  • Dark Forest Capital Management first reported a position in Caris Life Sciences in Q3 2025 and has held it in 4 quarters since.
  • Dark Forest Capital Management's Caris Life Sciences position peaked at $2.11M in Q4 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.